2026 Annual Seminar Schedule at a Glance

*Seminar Schedule Subject to Change.
Friday Schedule
Saturday Schedule
Sunday Schedule

Friday, April 24, 2026

12:00pm – 6:00pm
Registration Open

12:30pm – 2:00pm
Past Presidents Luncheon

1:00pm
Opening Remarks

1:05pm – 2:05pm (General Session)
Demystifying Pharmacist Prescribing in Oregon
Presented by Courtney Sellers and Gary Runyon

Navigate the evolving landscape of Oregon’s pharmacist prescribing authority with this essential update on statewide protocols, formulary requirements, and emerging regulatory changes. Gain the clinical clarity and professional advocacy tools needed to understand complex regulations, expand your practice potential, and contribute to the future of patient-centered care in Oregon. Join us to dive deeper into the history, structure, and function of the Public Health and Pharmacy Formulary Advisory Committee (PHPFAC), and learn how to actively engage in the process to contribute your own expertise toward the advancement of pharmacy practice 

2:10pm – 3:10pm (General Session)
Don’t Blame Me, Blame ChatGPT: Recognizing Cognitive Debt in Pharmacy Education
Presented by Maddie Frye and Ryan Gibbard
This presentation explores the concept of cognitive debt in pharmacy education and how increasing reliance on tools like AI may contribute to cognitive offloading among learners. Attendees will examine common behaviors that signal when students may be depending too heavily on external tools rather than developing their own clinical reasoning and knowledge retention. The session will highlight how these habits can accumulate into cognitive debt, potentially affecting long-term competence and confidence in practice. Participants will learn practical strategies preceptors and educators can use to encourage deeper learning, strengthen critical thinking, and reduce cognitive debt among pharmacy learners. 

3:10pm – 3:30pm
Break with Exhibitors

3:30pm – 5:30pm
Clinical Pearls

Metformin for Antipsychotic-Induced Weight Gain
Presented by Trixy Angelie Pilando Ibis, PharmD
Transition Pharmacy to Standard of Care Regulation
Presented by Mike Millard, BPharm
Medications that interfere with Continuous Glucose Monitors (CGMs)
Presented by Margaux Groff, PGY1 Pharmacy Resident
Be Informed: Updates to the 2026 AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke
Presented by Rosalind Wong, PharmD
Optimizing Medication Therapy: Identifying and Assessing Prescribing Cascades
Presented by Trang Tran
Rewiring Reward: GLP‐1 Agonists in Substance Use Disorders
Presented by Annie Saefong
Pharmacy Concierge Service on 340B Utilization, Apothecary Prescriptions and Hospital Admission Rates: a Quality Improvement Pilot Study
Presented by Zack McCall
Amoxicillin Clavulanate 875/125 given three times a day -- So crazy it just might work!
Presented by Young Yoon Ham

5:30pm – 7:00pm
Welcome Reception with Exhibitors 


Saturday, April 25, 2026

6:00am – 7:00am
Fun Run

7:00am – 5:30pm
Registration Open

7:30am – 8:00am
Continental Breakfast with Exhibits

8:00am – 8:05am
Opening Remarks

8:10am – 9:10am (General Session / Opening Session)
Oregon Indian Country: Tribal Sovereignty’s Impact on Health Care
Presented by Claymore Kills First
This talk explores how history, policy, and culture shape health care experiences for Tribal members in Oregon. It will discuss historical trauma, the impact of rural reservation geography on health care access, mistrust in health systems, and the importance of Tribal sovereignty and data sovereignty in research and care delivery. The presentation will also highlight efforts at the OHSU Knight Cancer Institute to build trust and improve cancer care through respectful partnerships with Tribal governments. 

9:15am – 10:15am (General Session)
The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks
Presented by Lavinia Salama, PharmD, BCACP, BCGP, BC-ADM, CDCES - Clinical Assistant Professor at Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences and Ambulatory Care Clinical Pharmacist at One Brooklyn Health, Pierre Toussaint Health Center Brooklyn, New York
Most patients with chronic kidney disease (CKD) are unaware they have it. Guidelines have established well-known risk factors for CKD to help identify and screen patients, but many patients remain unscreened and untreated, leading to kidney disease progression, cardiovascular disease, morbidity, and mortality. As the most accessible healthcare professionals, pharmacists are uniquely positioned to identify and screen patients at risk for CKD. Pharmacists can apply guideline recommendations to provide holistic care and improve outcomes and reduce cardiovascular risks for patients with CKD. This educational activity will discuss the cardiovascular risks of CKD and approaches to identifying and screening patients at risk of CKD. This activity will also provide strategies to implement guideline-recommended care of CKD and provide real-world examples of best practices in multidisciplinary care and patient education to equip and inspire pharmacists to bridge gaps across the cardiovascular-kidney-metabolic spectrum.
This presentation is provided by ASHP. Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

10:15am – 11:15am
Break with Exhibitors

10:15am – 11:15am
Poster Session

11:30am – 12:30pm
Lunch Buffet with Legislative Update and Office Induction 

12:30pm – 2:00pm (General Session)
Emergency Preparedness for Ambulatory & Health‑System Pharmacists Ensuring Continuity of Care, Patient Safety, and Community Resilience
Presented by Amy Cervan and Amber Taylor
Pharmacists play a critical role in protecting community health during emergencies — far beyond the boundaries of their clinic or health system. While every organization maintains an emergency operations plan, plans alone cannot stabilize chronic disease, maintain medication access, or prevent avoidable deterioration when disasters or cyber events disrupt care. This session focuses on how pharmacists can anticipate disruptions, safeguard medication access, support vulnerable populations, and collaborate with public health and emergency response partners. Rather than emphasizing internal preparedness tasks, this training highlights the outward-facing role pharmacists play in strengthening community resilience. 

2:00pm – 2:30pm
Break – Refreshments, Section Networking, Fundraising

2:30pm – 3:30pm (Track A)
PrEPared in Primary Care: Putting PrEP into Practice
Presented by Jess Potter
This presentation will review the four currently available options for HIV pre-exposure prophylaxis (PrEP), with particular focus on the long-acting injectable agents, cabotegravir and lenacapavir. It will outline how to identify patients who may benefit from PrEP and compare key features of available therapies. Practical counseling considerations, medication logistics/coverage, and monitoring requirements will be discussed. A patient case will illustrate real-world decision-making from initial evaluation through ongoing management. 

2:30pm – 3:30pm (Track B)
Rewriting Disease: Gene Therapy and Gene Editing in Today’s Pharmacy
Presented by Sigrid Roberts and Nicola Carter 
Gene editing, or the ability to manipulate the genome, is one of the fastest growing medical technologies. This session will provide an overview of the history of gene therapy and gene editing, the molecular mechanisms of gene editing, and discuss the advantages and challenges of implementing this type of therapy. Currently available FDA approved pharmaceutical treatments based on gene editing will be reviewed. The objective of this session is to give attendants an overview and basic understanding of gene editing, its current use and future perspectives. 

3:35pm – 4:35pm (Track A)
GDMT Without Gaps: Building and Maintaining Optimal Therapy Across the Patient Journey
Presented by Alyssa Rabon
Building and optimizing heart failure management with guideline-directed medical therapy (GDMT) is essential for improving patient outcomes. This session provides practical, evidence-based strategies to optimize GDMT across the continuum of care -- including during ICU admission, preparing for hospital discharge, and in ambulatory clinic follow-up. Participants will learn how to identify clinical opportunities for initiation and titration of GDMT, identify and overcome transitions of care barriers, and create a regimen that supports medication adherence to optimize patient outcomes. 

3:35pm – 4:35pm (Track B)
FDA-Approved Anti-Amyloid Therapy for Alzheimer's Disease: New Evidence and Practice Updates
Presented by Marketa Marvanova

The therapeutic landscape for Alzheimer’s disease has evolved with the approval of anti-amyloid monoclonal antibodies targeting beta-amyloidpathology. This session will review current evidence and practice updates for FDA-approved therapies, including lecanemab and donanemab. Topicsinclude mechanisms of action, patient selection, and the role of these agents in early Alzheimer’s disease. The program will also discuss recent clinicaltrial findings, regulatory updates, dosing strategies, and key safety monitoring considerations.

4:45pm – 5:00pm
Pie-in-the-Face Fundraising
Located on the Homestead Lawn

6:00pm – 8:00pm
Awards Celebration
Doors & Auction Open: 6:00pm
Dinner Service Begins: 6:30pm
Saddle up with OSHP at the Annual Seminar’s Saturday Night Awards Dinner, starting at 6:00 PM! We’re heading out West for a frontier-inspired celebration filled with boots, hats, and plenty of good company. Dust off your best cowboy boots, denim, and Western flair as we gather for a night of hearty food, lively fun, and great conversation.


Sunday, April 26, 2026

7:30am – 8:30am
Breakfast and Registration

8:00am – 8:05am
Opening Remarks

8:05am – 9:05am (General Session)
BOP Law Update
Presented by Gary Runyon

Join Oregon Board of Pharmacy Executive Director Gary Runyon and Compliance Officer Jane Lee for an essential law update designed to keep yourpractice compliant and informed. This session will break down recent legislative changes alongside critical rule amendments impacting the practice ofpharmacy in Oregon. Attendees will learn effective strategies for navigating state resources, explore common institutional compliance pitfalls to avoid,and discover how to actively engage with the Board to shape the future of pharmacy practice.

9:10am – 10:10am (General Session)
From Guidelines to Practice: An Update on High Blood Pressure Management

Presented by Abby Frye
This session will provide a comprehensive overview of the 2025 ACC/AHA high blood pressure guidelines. Attendees will learn about the most significant changes from the 2017 guidelines and explore the evidence that supports these updates – including terminology, cardiovascular risk assessment, treatment thresholds, and management of specific populations. Participants will leave with practical takeaways to help them implement the latest recommendations into clinical practice. 

10:15am – 10:30am
Break

10:30am – 11:30am (General Session)
Considerations for Safe Prescribing in Older Adults
Presented by Katie Bowden

Recognize challenges for safe medication use and potentially inappropriate medications Identify safety strategies and resources available to evaluate clinically important prescribing concerns Apply concepts using a safety protocol for deprescribing through a patient case 

11:30am – 11:40am (General Session)
Closing Remarks

11:45am
Seminar Ends

*Schedule, topics, presenters and CE Type schedule to change.